medigraphic.com

2007, Number 2

<< Back Next >>

Enf Infec Microbiol 2007; 27 (2)

Hepatitis C virus seroprevalence in abload-donors population and suspecious hepatitis patients refered to a bload bank from Mexico state

Cruz GJ, Mancilla CR, Quijano VJR

Language: Spanish
References: 22
Page: 49-54
PDF size: 80.84 Kb.


ABSTRACT

Background. Hepatitis C virus (HCV) is an important issue of worldwide health, it is known that this illness is widely disseminated around the world, nevertheless in Mexico there is little information about HCV prevalence, so the aim of this study was to investigate the seroprevalence of viral antibodies against HCV, in a mexican population at the Gineco-obstetric Hospital No. 60 of the Mexican Social Security Institute.
Material and methods. Using an enzymatic immunoassay in serum human, seroprevalence rate of seropositive donors and seropositive patients was calculate. A polimerase chained reaction was made subsequently in each one sample. The data analysis was made by descriptive statistical.
Results. In donors population 94/13,738 (0.68%) was ELISA against HCV positive and the active infection was determinated in 0.13%. In suspected-HCV patients 304/3,264 (9.3%) ELISA against HCV resulted positive and 2.5% had detectable qualitative PCR.
Conclusions: The prevalence of antibodies against hepatitis C in our population was similar to that reported in previous studies carried out in Mexico.


REFERENCES

  1. Lauer GM, Walker BD. Hepatitis C virus infection. New England J Medical 2001; 345: 41-52.

  2. Méndez SN. National Consensus of Hepatitis C. Annals Hepatol 2002; 3: 148-154.

  3. Gresens CJ. The Disappearance of Transfusion-Transmitted Hepatitis C Virus Infections in the United States. Clin Liver Dis 2001; 5: 210-219.

  4. Vera de León L, Juárez NJA, Díaz GM, Méndez NJ, Chirino SRA, Dehesa VM y cols. Panorama epidemiológico y situacional de la hepatitis C en México. Rev Gastroenterol Méx 2005; 70: 25-32.

  5. Memon MI, Memon MA. Hepatitis C: a epidemiological review. J Vir Hepathol 2002; 9: 84-100.

  6. Ladrón de Guevara L, Gómez PN, Vázquez CM, García MS, Di Silvio M. Prevalencia y factores de riesgo para hepatitis C en donadores de sangre. Rev Gastroenterol Méx 2002; 67: 11-16.

  7. Bucci JR. Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation. J Am Soc Nephrol 2002; 13: 2974-2982.

  8. Nguyen HA. Natural history of chronic hepatitis C: Identifying a window of opportunity for intervention. J Lab Clin Med 2001; 137: 146-154.

  9. Guerrero RJF, Castañeda A, Rodríguez MM. Prevalence and risk factors associated to hepatitis “C” in blood donors in Durango México. Salud Pública Mex 1996; 38: 94-100.

  10. Ayala GJJ, Guerra AFJ, Mora BP, Casillas RA. Prevalencia de marcadores virales para hepatitis B, C y virus de la inmunodeficiencia humana en donadores de sangre voluntarios en el Noreste de México. Rev Gastroenterol Méx 1997; 62: 250-253.

  11. Hernández PRE, Frías SJA, Del Ángel GO. Seroprevalencia de anticuerpos contra el virus de la hepatitis C en donadores de sangre del Hospital Central Militar. Salud Pública Méx 1994; 36: 538-540.

  12. Gamboa R, Gaxiola CR, Guana FR, Silva MC, Becerra- LG. Seroprevalence of hepatitis C virus antibodies in obstetric patients at the Nuevo Hospital Civil de Guadalajara. Ginecol Obstet Mex 1994; 62: 399-402.

  13. Carreto VMA, Carrada BT, Martínez MA. Seroprevalence of HBV, HCV and HIV in blood donors in Irapuato, Mexico. Salud Pública Méx 2003; 45: S690-S693.

  14. Centers for Disease Control and Prevention Hepatitis A to E. Available at: www.cdc.gov/ncidod/diseases/hepatitis/slideset/httoc.htm (accessed Nov. 25, 1996)

  15. Picchio GR, et al. High prevalence of infection with a single hepatitis C virus genotype in a small rural community of Argentina. Liver Int 2006; 26: 660-665.

  16. Merino-Conde E, Orozco JA, Rojo-Medina J, Tovar A. Prevalence of hepatitis C virus among candidates for blood donation at the Hospital General de México. In Vivo 1994; 8: 621-623.

  17. Ortiz IFJ, Figueroa DR, Lara SJ, Arredondo GJL, Ahued AJR. Prevalence of serologic markers of hepatitis A, B, C and D viruses in pregnant women. Salud Pública Méx 1996; 38: 317-322.

  18. Méndez SN, Bautista GH, Sánchez GRH, Bordes AJ, Uribe EM. Prevalencia de la hepatitis B y C en donadores de sangre en un Hospital de Tercer Nivel de la Ciudad de México. Salud Pública Méx 1999; 41: 475-478.

  19. Chiquete E, Sánchez LV, Maldonado M, Quezada D, Panduro A. Prediction of the hepatitis C viremia using immunoassay data and clinical expertise. Annals Hepatol 2005; 4: 107-114.

  20. Marín LA, Vargas VF. Risk factor for Hepatitis C virus infection. Blood banks in Mexico. Rev Gastroenterol Méx 2002; 67.

  21. Benítez AG, et al. Prevalencia del virus de la hepatitis C en el Banco de Sangre del Centro Médico Nacional La Raza. Rev Med Inst Méx Seg Soc 2006; 44 (3): 227-233.

  22. Méndez SN, et al. Prevalence of hepatitis C infection in a population of asymptomatic people in a checkup unit in Mexico city. Dig Dis Sci 2005 Apr; 50(4): 733-737.




2020     |     www.medigraphic.com